Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.
about
Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapyInterventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factorsInterventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapyInterventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentOral Mucositis Induced By Anticancer TherapiesTreatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical updateManagement of regorafenib-related toxicities: a reviewWhat are the predictive factors in the risk and severity of chemotherapy-induced gastrointestinal toxicity?Mammalian target of rapamycin inhibitor-associated stomatitisTLR4/PKC-mediated tight junction modulation: a clinical marker of chemotherapy-induced gut toxicity?Oral complications in hematopoietic stem cell recipients: the role of inflammationChemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsPalifermin: role in the prevention of chemotherapy- and radiation-induced mucositis5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imagingOlmesartan decreased levels of IL-1β and TNF-α, down-regulated MMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis modelBreakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment.Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinumNoninvasive direct detection of ocular mucositis by in vivo confocal microscopy in patients treated with S-1Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group.Radiation-Induced Oral MucositisEffect of dietary boron on 5-fluorouracil induced oral mucositis in rats.Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositisIrinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons.New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal InjuryEndoscopic scoring of late gastrointestinal mucosal damage after adjuvant radiochemotherapyManagement of Chemoradiation-Induced Mucositis in Head and Neck Cancers With Oral Glutamine.Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis.Role of inducible nitric oxide synthase pathway on methotrexate-induced intestinal mucositis in rodents.Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children.Role of antioxidants in buccal mucosa cells and plasma on the incidence and severity of oral mucositis after allogeneic haematopoietic cell transplantation.Long term chemoradiotherapy-related dental and skeletal complications in a young female with nasopharyngeal carcinomaEffect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: a pilot studyEfficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in miceThe Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis.MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
P2860
Q24186965-5B2EF8C8-5F30-41EC-9A60-07930374BDBBQ24187456-D3B6272C-33B3-4515-B503-C7E2A601A2F8Q24188283-18CD423C-ACDB-4996-BEF8-1FA7F4E077E0Q24235217-54940470-CCEC-42DA-ABC1-D7829B6E1211Q24235482-058A63A2-0223-41FE-A29A-CA07A0FD0CBFQ24243046-0F093AFA-3CC7-40B2-8F78-BE70DD3A80A0Q24246310-EA507B85-1E8A-441F-99E7-B478A092B599Q26777493-DDD14FDA-F2B7-4517-AD1F-85356587E741Q26778004-9BF7A2B9-F671-4735-BB0D-73968FD4F0B1Q26795561-78362B02-083A-4C90-A42A-432247B0AE08Q26798171-87B1653F-D329-4FCD-9113-F0AC24CFD6B9Q26825301-0F3EC8EE-D74C-4F81-9DFF-0721D1E79B89Q27015742-264817BC-0964-4959-B138-6E557BB04310Q27027650-3137FC3D-D637-46F5-89BF-20ABFCC96CC5Q28079705-42AEC447-6973-4A3F-B52A-B376EF1BE153Q28280759-3867D29B-937F-4A8C-A119-9036D975B73EQ28481421-962BD32E-B065-49F6-8A80-A824713218DDQ28542802-411065CF-B99A-4892-9D12-60DDBFF1666AQ31143906-9F7A2609-90D3-4734-8575-0E2ABA865EDDQ33217865-74620F7F-B265-4A51-9D70-EDEBDB772240Q33293726-63E08B89-9B9D-4FCB-86C9-654FA74E3EEFQ33522631-57F6BDFE-2B4B-427A-ABC2-30AB667EBBD9Q33559486-2E7FD9DB-82D7-4BD4-B92B-CC0E73691DBDQ33711362-3A28C7E1-3536-4E4A-A720-A3B599BB98ECQ33741338-050E879E-0F37-4082-AD40-2157C0E22DD8Q33753588-837C9AE8-2E8F-4704-A3BC-E32A318EBAD3Q33774788-715B11EB-F1D8-474C-BC4F-7BA22FC9DBF2Q33774917-0D6C9A92-B2A3-4F9B-9E36-D4A56A2617EEQ33867589-B6D24490-BADD-488F-A81C-2239FCC05F6BQ33872786-C7BC8EC3-46BC-4633-A98C-04469DEA9514Q33973916-7724516D-7C1A-4E44-AC22-803BC2968F3DQ33994068-CCA29C20-BD4A-4EE4-A340-605139871EFCQ34023501-60C2AFFE-0967-4F83-9FCE-55132AA2744BQ34037221-D07E8BDC-C465-4DA0-A463-B8DD0091E20BQ34041885-F60FF09B-D716-4251-8599-DE3222C5840CQ34071285-6445C944-7763-460A-9B79-5595F6F71395Q34080590-5F6D9F46-DFA0-40CE-A034-9ACDF5AABD48Q34095827-FAADCD80-5958-4046-8238-FF304AC72072Q34150143-70720CF1-1813-4F08-8023-EBD20DE63F66Q34180792-66C5275E-A1DA-4996-8FE6-797AA6B80F49
P2860
Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Perspectives on cancer therapy ...... and consequences for patients.
@ast
Perspectives on cancer therapy ...... and consequences for patients.
@en
type
label
Perspectives on cancer therapy ...... and consequences for patients.
@ast
Perspectives on cancer therapy ...... and consequences for patients.
@en
prefLabel
Perspectives on cancer therapy ...... and consequences for patients.
@ast
Perspectives on cancer therapy ...... and consequences for patients.
@en
P2093
P356
P1433
P1476
Perspectives on cancer therapy ...... and consequences for patients.
@en
P2093
B Nebiyou Bekele
Dorothy Keefe
Douglas E Peterson
Edward B Rubenstein
International Society for Oral Oncology
J Peter Donnelly
Judith Raber-Durlacher
Linda S Elting
Mark Schubert
Martin Hauer-Jensen
P304
P356
10.1002/CNCR.20162
P407
P433
P577
2004-05-01T00:00:00Z